Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study

Tomoko Kobayashi; Shintaro Iwama; Yoshinori Yasuda; Norio Okada; Takayuki Okuji; Masaaki Ito; Takeshi Onoue; Motomitsu Goto; Mariko Sugiyama; Taku Tsunekawa; Hiroshi Takagi; Daisuke Hagiwara; Yoshihiro Ito; Hidetaka Suga; Ryoichi Banno; Kenji Yokota; Tetsunari Hase; Masahiro Morise; Naozumi Hashimoto; Masahiko Ando; Yasushi Fujimoto; Hideharu Hibi; Michihiko Sone; Yuichi Ando; Masashi Akiyama; Yoshinori Hasegawa; Hiroshi Arima

doi:10.1136/jitc-2020-000779

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

XML

Clinical/translational cancer immunotherapy

Original research

Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password